References

Oligodendrocytes Do Not Export NAA-Derived Aspartate In Vitro

10.1007/s11064-016-1985-y · 2017 · External reference

Gene and Cellular Therapies for Leukodystrophies

10.3390/pharmaceutics15112522 · 2023 · External reference

Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease

10.1016/j.bbmt.2018.06.020 · 2018 · External reference

An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies

10.1080/14737175.2020.1699060 · 2020 · External reference

Gene therapy for leukodystrophy: progress, challenges and opportunities

10.1517/21678707.2016.1151352 · 2016 · External reference

Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy

10.1016/j.jconrel.2025.114307 · 2025 · External reference

Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy

10.1016/j.omtm.2024.101248 · 2024 · External reference

Distinct patterns of complex rearrangements and a mutational signature of microhomeology are frequently observed in PLP1 copy number gain structural variants

10.1186/s13073-019-0676-0 · 2019 · External reference

The arylsulphatase A gene and molecular genetics of metachromatic leucodystrophy

10.1136/jmg.31.9.663 · 1994 · External reference

Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice

10.1016/s1525-0016(03)00002-9 · 2003 · External reference

Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy

10.1111/j.1750-3639.2010.00393.x · 2010 · External reference

Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy

10.1126/science.1233158 · 2013 · External reference

Unresolved reference

2026 · External reference

Leukodystrophies in Children: diagnosis, Care, and Treatment

10.1542/peds.2021-053126 · 2021 · External reference

The burden of inherited leukodystrophies in children

10.1212/wnl.0b013e3181eee46b · 2010 · External reference

Krabbe disease successfully treated via monotherapy of intrathecal gene therapy

10.1172/jci133953 · 2020 · External reference

Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy

10.1016/j.ymthe.2023.11.014 · 2024 · External reference

Krabbe disease: new hope for an old disease

10.1016/j.neulet.2021.135841 · 2021 · External reference

Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1/2 clinical trial

10.1016/j.ymgme.2020.07.002 · 2020 · External reference

CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders

10.3389/fgeed.2025.1553590 · 2025 · External reference

Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy

10.1016/b978-0-12-386509-0.00010-7 · 2012 · External reference

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

10.1126/science.1171242 · 2009 · External reference

Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy

10.1002/humu.22919 · 2016 · External reference

A systematic review on the birth prevalence of metachromatic leukodystrophy

10.1186/s13023-024-03044-w · 2024 · External reference

Stem cell derived oligodendrocytes to study myelin diseases

10.1002/glia.23733 · 2020 · External reference

Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology

10.1111/cge.12811 · 2016 · External reference

Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy

10.1093/hmg/2.11.1841 · 1993 · External reference

RNA therapeutics: rNAi and antisense mechanisms and clinical applications

10.14304/surya.jpr.v4n7.5 · 2016 · External reference

A new familial infantile form of diffuse brain-sclerosis

10.1093/brain/awt232 · 2013 · External reference

POLR3-related leukodystrophy: how do mutations affecting RNA polymerase III subunits cause hypomyelination?

10.12703/r/10-12 · 2021 · External reference

Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism

10.1136/jmedgenet-2012-101357 · 2013 · External reference

D-Aspartate treatment attenuates myelin damage and stimulates myelin repair

10.15252/emmm.201809278 · 2019 · External reference

Lysosomal arylsulfatase deficiencies in humans: chromosome assignments for arylsulfatase A and B

10.1073/pnas.76.4.1957 · 1979 · External reference

Mutation in POLR3K causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation

10.1212/nxg.0000000000000289 · 2018 · External reference

The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder

10.1016/s0166-2236(98)01319-8 · 1999 · External reference

Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: retrospective Study on Predictors of Outcomes

10.3390/pharmaceutics14122778 · 2022 · External reference

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy

10.1056/nejmoa2405541 · 2024 · External reference

Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy

10.1056/nejmoa1700554 · 2017 · External reference

Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

10.1056/nejmoa2400442 · 2024 · External reference

Initial Biomarker and Clinical Findings from the CANaspire Canavan Disease Gene Therapy Trial: Exploration of Connections between NAA and Disease Severity

2023 · External reference

Pelizaeus-Merzbacher disease: on the cusp of myelin medicine

10.1016/j.molmed.2024.03.005 · 2024 · External reference

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management

10.1186/1750-1172-7-51 · 2012 · External reference

Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease

10.1056/nejmoa042604 · 2005 · External reference

P014: first-in-human phase 1/2 trial of intravenous FBX-101 with cord blood transplantation increases GALC, brain and motor development in infantile Krabbe

2023 · External reference

O30: REKLAIM: a firstin-human phase Ib clinical trial of FBX-101 (AAVrh10. GALC) intravenously administered after UCBT for infantile Krabbe disease

10.1016/j.gimo.2024.100875 · 2024 · External reference

Atidarsagene autotemcel for metachromatic leukodystrophy

2024 · External reference

Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease

10.1016/j.omtm.2021.01.009 · 2021 · External reference

N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase

10.1016/j.nbd.2016.10.001 · 2016 · External reference

Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice

10.3389/fnmol.2022.1061257 · 2022 · External reference

Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification

10.1016/j.jstrokecerebrovasdis.2010.11.008 · 2011 · External reference

Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy

10.1056/nejmoa2405727 · 2025 · External reference

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

10.1016/s0140-6736(21)02017-1 · 2022 · External reference

Metachromatic leukodystrophy: a single-center longitudinal study of 45 patients

10.1002/jimd.12388 · 2021 · External reference

Lenmeldy (atidarsagene autotemcel) for individuals with early metachromatic leukodystrophy (MLD): a therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

10.1016/j.gimo.2025.103432 · 2025 · External reference

Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options

10.1111/j.1651-2227.2008.00648.x · 2008 · External reference

Current Therapeutic Approaches in Leukodystrophies: a Review

10.1177/0883073818792313 · 2018 · External reference

Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients

10.1001/jamaneurol.2016.2067 · 2016 · External reference

Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy

10.1080/14712598.2022.2124857 · 2022 · External reference

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic NOTCH3 Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years

10.1161/strokeaha.121.036307 · 2022 · External reference

Clinical Approach to Genetic Cerebral Arteriopathy in the Adult Patient With Ischemic Stroke

10.1212/nxg.0000000000200182 · 2024 · External reference

Clinical aspects of globoid cell and metachromatic leukodystrophies

1971 · External reference

Diagnosis of Krabbe’s infantile leucodystrophy

10.1136/jnnp.26.3.195 · 1963 · External reference

Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease

10.1002/ana.25118 · 2018 · External reference

Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy

10.1186/s40478-020-01093-3 · 2020 · External reference

Leukodystrophy incidence in Germany

10.1002/(sici)1096-8628(19970905)71:4<475::aid-ajmg20>3.0.co;2-c · 1997 · External reference

Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease

10.3390/genes14081517 · 2023 · External reference

Efficacy and Safety of a Krabbe Disease Gene Therapy

10.1089/hum.2021.245 · 2022 · External reference

Canavan disease: clinical features and recent advances in research

10.1111/ped.12422 · 2014 · External reference

Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene

10.1177/08830738030180090801 · 2003 · External reference

Pelizaeus-Merzbacher Disease: molecular and Cellular Pathologies and Associated Phenotypes

10.1007/978-981-32-9636-7_13 · 2019 · External reference

Acute diffuse infantile sclerosis of the brain (Krabbe’s disease); a report of two cases in sibs

10.1111/j.1651-2227.1953.tb05567.x · 1953 · External reference

Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort

10.1186/1750-1172-9-18 · 2014 · External reference

Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: the Right Path towards Therapy

10.3390/biomedicines11123333 · 2023 · External reference

POLR3 gene and protein expression dynamics in 4H leukodystrophy using iPSC-derived neuronal lineages

10.1016/j.scr.2025.103805 · 2025 · External reference

Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy

10.1093/brain/awx016 · 2017 · External reference

Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease

10.1002/jnr.22233 · 2009 · External reference

Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1/2 trial

10.1038/s41591-025-03919-w · 2025 · External reference

GFAP mutations in Alexander disease

10.1016/s0736-5748(02)00019-9 · 2002 · External reference

Stem cell and gene therapies for leukodystrophies

10.1016/j.omtm.2025.101527 · 2025 · External reference

Single systemic administration of a gene therapy leading to disease treatment in metachromatic leukodystrophy arsa knock-out mice

10.1523/jneurosci.1829-22.2023 · 2023 · External reference

Clinical course and endocrine dysfunction in X-linked adrenoleukodystrophy: a case series

2023 · External reference

Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy

10.1093/braincomms/fcz048 · 2020 · External reference

Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation

2019 · External reference

Eine eigenartige familiär-hereditäre erkrankungsform (Aplasia axialis extracorticalis congenita)

10.1007/bf02893591 · 1910 · External reference

Alexander disease

10.1523/jneurosci.5384-11.2012 · 2012 · External reference

Gene therapy for the leukodystrophies: from preclinical animal studies to clinical trials

10.1016/j.neurot.2024.e00443 · 2024 · External reference

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report

10.1182/blood-2011-01-329235 · 2011 · External reference

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A

10.1038/s41598-021-99979-2 · 2021 · External reference

X-linked adrenoleukodystrophy

10.1038/ncpneuro0421 · 2007 · External reference

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

10.1038/361726a0 · 1993 · External reference

Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions

10.3389/fneur.2023.1219324 · 2023 · External reference

10.1016/j.bbmt.2011.09.013

10.1016/j.bbmt.2011.09.013 · 2011 · External reference

The landscape of pediatric genetic white matter disorders at a tertiary referral hospital in Upper Egypt and the report of 31 novel variants

10.1186/s13052-025-02031-6 · 2025 · External reference

Emerging cellular themes in leukodystrophies

10.3389/fcell.2022.902261 · 2022 · External reference

Neurogenetics of Pelizaeus-Merzbacher disease

10.1016/b978-0-444-64076-5.00045-4 · 2018 · External reference

Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: review of Clinical Manifestations as Foundations for Therapeutic Development

10.3389/fneur.2021.788168 · 2021 · External reference

A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies

10.1016/j.ymgme.2014.12.434 · 2015 · External reference

Leukodystrophies

10.1007/978-1-4614-0653-2_13 · 2012 · External reference

The Challenge of Gene Therapy for Neurological Diseases: strategies and Tools to Achieve Efficient Delivery to the Central Nervous System

10.1089/hum.2020.105 · 2021 · External reference

Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism

10.1038/gt.2016.62 · 2016 · External reference

Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease

10.34172/bi.2020.13 · 2020 · External reference

10.1101/2025.03.12.642609

10.1101/2025.03.12.642609 · External reference

Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series

10.1182/bloodadvances.2023011836 · 2024 · External reference

Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy

10.1089/hum.2020.269 · 2021 · External reference

Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments

10.1016/j.ymthe.2018.10.017 · 2018 · External reference

Leukodystrophies and genetic leukoencephalopathies in children

10.1016/j.neurol.2019.04.003 · 2020 · External reference

Mendelian adult-onset leukodystrophy genes in Alzheimer’s disease: critical influence of CSF1R and NOTCH3

10.1016/j.neurobiolaging.2018.01.015 · 2018 · External reference

Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

10.1016/j.gimo.2023.100835 · 2023 · External reference

Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

10.1016/s0140-6736(16)30374-9 · 2016 · External reference

Hematopoietic stem cell transplantation in leukodystrophies

10.1016/b978-0-323-99209-1.00017-x · 2024 · External reference

Intracerebral gene therapy in children with metachromatic leukodystrophy: results of a phase I/II trial

2018 · External reference

Metachromatic Leukodystrophy: diagnosis, Modeling, and Treatment Approaches

10.3389/fmed.2020.576221 · 2020 · External reference

Alexander disease: an astrocytopathy that produces a leukodystrophy

10.1111/bpa.12601 · 2018 · External reference

New therapeutic approaches for Krabbe disease: the potential of pharmacological chaperones

10.1002/jnr.23762 · 2016 · External reference

Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III

10.1038/ncomms8623 · 2015 · External reference

Microbiota gut-brain axis: implications for pediatric-onset leukodystrophies

10.3389/fnut.2024.1417981 · 2024 · External reference

Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms

10.1007/s00401-017-1739-1 · 2017 · External reference

Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter

10.1002/ana.10112 · 2002 · External reference

Vanishing white matter disease

10.1016/s1474-4422(06)70440-9 · 2006 · External reference

Diagnosis, prognosis, and treatment of leukodystrophies

10.1016/s1474-4422(19)30143-7 · 2019 · External reference

The reflection of histology in MR imaging of Pelizaeus-Merzbacher disease

1989 · External reference

Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy

10.1001/jamaneurol.2013.629 · 2013 · External reference

Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders

10.1016/j.spen.2012.10.001 · 2012 · External reference

Case definition and classification of leukodystrophies and leukoencephalopathies

10.1016/j.ymgme.2015.01.006 · 2015 · External reference

Leukodystrophies

10.1212/con.0000000000000560 · 2018 · External reference

Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed

10.1111/petr.13773 · 2020 · External reference

Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction

10.1002/acn3.50975 · 2020 · External reference

Treatment of leukodystrophies: advances and challenges

10.1016/j.ejpn.2025.03.016 · 2025 · External reference

Overlapping Protein Accumulation Profiles of CADASIL and CAA: is There a Common Mechanism Driving Cerebral Small-Vessel Disease?

10.1016/j.ajpath.2020.11.015 · 2021 · External reference

The impact of leukodystrophies on parents’ lives

10.1093/jpepsy/jsaf072 · 2025 · External reference

Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review

10.3389/fneur.2025.1573052 · 2025 · External reference

Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders

10.1016/j.omtm.2024.101357 · 2024 · External reference